ERK inhibitors

Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

Crystalline forms of PARP inhibitors

ENZALUTAMIDE POLYMORPHIC FORMS AND ITS PREPARATION

Compounds as CRTH2 antagonist and uses thereof

Crystalline forms of ferric maltol

Method for producing amino acid crystals and method for producing protein crystals

Crystal of alkali metal N-acetylneuraminate anhydrate, and process for producing same

SALT OF NAPHTHYRIDINE CARBOXYLIC ACID DERIVATIVE

Solid forms of an antiviral compound

Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase

Azole benzene derivative and crystalline form thereof

PROCESSES FOR THE PREPARATION OF EMPAGLIFLOZIN

NOVEL FORM OF RIMSULFURON, A PROCESS FOR ITS PREPARATION AND USE OF THE SAME

Method of producing (4R,12aS)-7,9-dihalo-4-methyl-3,4,12,12a-tetrahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-diones

CRYSTALLINE FORMS OF PALBOCICLIB

Crystalline form of afatinib dimaleate

Process for the preparation of polymorphic forms of nilotinib hydrochloride

Acid-addition salt of Trk-inhibiting compound

Crystal modifications of elobixibat

Method for resolution of citalopram intermediate 5-cyano diol

Solid forms of nilotinib hydrochloride

Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same

Tetrahydropyrrolo[3,4-D][1,3]thiazine-derivative as BACE inhibitor

Crystalline form of 1-(1-methyl-1H-pyrazol-4-yl)-N-((IR,5S,7S)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1H-indole-3-carboxamide

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Crystalline forms of a BACE inhibitor, compositions, and their use

Crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{[1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol

Salts of nilotinib and polymorphs thereof

Processes for preparing ASK1 inhibitors

Zinc oxide complexes

Preparation and uses of obeticholic acid

Methods of separating gemcitabine-phosphate diastereoisomers

CRYSTALLINE SALTS OF (Z)-O-OCTADEC-9-EN-1-YL O,O-DIHYDROGEN PHOSPHOROTHIOATE

Intermediates in the synthesis of cephalosporin compounds

SOLID SALT FORM OF ALPHA-6-MPEG6-O-HYDROXYCODONE AS OPIOID AGONISTS AND USES THEREOF

Solid state forms of ibrutinib

Crystalline forms of a bruton's tyrosine kinase inhibitor

Ibrutinib solid forms and production process therefor

Crystal forms of glutaminase inhibitors

Crystalline forms of a BACE inhibitor, compositions, and their use

Forms and compositions of an ERK inhibitor

Methods and compositions for gamma-glutamyl cycle modulation

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

6-aryl amino pyridone formamide compound crystal and preparation method therefor

Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro- 1-6-naphthyridine-3-carbox-amide and the purification thereof for use as an active pharmaceutical ingredient

CRYSTALLINE FORM

Crystalline forms of vilazodone hydrochloride and vilazodone free base

Salt of monocyclic pyridine derivative and crystal thereof

COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM

Salts of an epidermal growth factor receptor kinase inhibitor

Polymorphic forms of ivabradine hydrochloride

Polymorphic forms of pitavastatin sodium

Crystalline form of nicotinamide riboside

TH-302 solid forms and methods related thereto

Crystalline free bases of C-Met inhibitor or crystalline acid salts thereof, and preparation methods and uses thereof

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases

NOVEL CRYSTALLINE FORMS OF TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE SODIUM SALT

Crystal of azole benzene derivative

Polymorphic forms of naltrexone

Preparation and use of crystalline beta-D-nicotinamide riboside

Crystal form of tenofovir prodrug, preparation method thereof, and method of use thereof

Chemical compounds

Crystalline form of baricitinib

CRYSTALLINE FORMS OF OLAPARIB AND MANUFACTURING PROCESSES THEREFOR

Crystalline Form of Pemirolast

Treatment of antimony bearing residues for production of potassium antimony tartrate

SODIUM (2R,5S,13AR)-7,9-DIOXO-10-((2,4,6-TRIFLUOROBENZYL)CARBAMOYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPIN-8-OLATE

Acetate salt of buprenorphine and methods for preparing buprenorphine

Process for preparation of (2S, 5R)-7-oxo-6-sulphooxy-2-[((3R)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]-octane

1,3,4-thiadiazole compounds and their use in treating cancer

Process of preparing potassium salt of Azilsartan medoxomil

Process for producing alkynylketone derivative

NEW CRYSTAL FORM OF PANTOPRAZOLE SODIUM COMPOUND AND PREPARATION METHOD THEREFOR

Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses

Preparation of 2,6- and 2,7-disubstituted anthraquinone derivatives

Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoate

ATRASENTAN MANDELATE SALTS

Crystalline salts of (S)-6-((1 acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide

IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE

Crystalline forms of a prolyl hydroxylase inhibitor

PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHODS AND USE THEREOF

Dasatinib salts

Pyridone derivatives having tetrahydropyranylmethyl groups

Cocrystal, production method thereof, and medicament containing cocrystal

Form A of mesylate for nicotinamide derivatives and preparation method and application thereof

CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG

Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

Crystalline and amorphous forms of Olaparib

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

Choline cocrystal of epalrestat

Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds

Fenfluramine compositions and methods of preparing the same

Pressure driven flow crystallizer

Crystalline forms of quinolone analogs and their salts

Solid state forms of a PDE10 inhibitor

Fumagillol derivatives and polymorphs thereof

Process for the preparation of dapagliflozin

Form of spirodiclofen, a process for its preparation and use the same

STABLE POLYMORPH FORM B OF TAPENTADOL HYDROCHLORIDE

Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same

Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof

ADDITION SALTS OF (S)-2-(1-(6-AMINO-5-CYANOPYRIMIDIN-4-YLAMINO)ETHYL)-4-OXO-3-PHENYL-3,4-DIHYDROPYRROLO[1,2-F][1,2,4]TRIAZINE-5-CARBONITRILE

PYRIMIDINE COMPOSITIONS, ULTRA PURE COMPOSITIONS AND SALTS THEREOF, METHODS OF MAKING THE SAME, AND METHODS OF USING THE SAME FOR TREATING HISTAMINE H4 RECEPTOR (H4) MEDIATED DISEASES AND CONDITIONS

Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced cristalline polymorph of the anhydrous form, use thereof for the treatment of Alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharmaceutical composition

Co-crystal of dapagliflozin with citric acid

Crystalline forms of neurotrophin mimetic compounds and their salts

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

AMORPHOUS FORM AND NEW CRYSTALLINE FORMS OF MACITENTAN

Tranilast compositions and cocrystals

EMM-28, a novel synthetic crystalline material, its preparation and use

Crystalline solvate forms of a pharmaceutical

Topical Pharmaceutical Formulations For Treating Inflammatory-Related Conditions

Low pH sysnthesis of zinc-lysine complex

Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same

Form of tribenuron-methyl, a process for its preparation and use of the same

Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease

Valbenazine salts and polymorphs thereof

Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

NOVEL CRYSTALLINE POLYMORPHS OF PYRIDINE DERIVATIVE AND METHOD FOR PRODUCING THE SAME

Solid state forms of sofosbuvir

Crystalline, anhydrous forms of oxymorphone hydrochloride

Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Crystalline forms of pemetrexed diacid and processes for the preparation thereof

Novel Crystalline Form of Levomefolate

Method for preparing agomelatine cocrystals and composition containing same

Synthesis of zinc-lysine complex from zinc chloride

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Process for the synthesis of (R)-praziquantel

Salts of a pim kinase inhibitor

Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl] pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acid

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

POLYMORPHIC FORMS OF 3-(4-AMINO-1-OXO-1,3 DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE

POLYCYCLIC LPA1 ANTAGONIST AND USES THEREOF

Process for preparing a novel crystalline form of metsulfuron-methyl and use of the same

METHOD OF PREPARATION OF ANTIVIRAL COMPOUNDS AND USEFUL INTERMEDIATES THEREOF

INHIBITORS OF BRUTON'S TYROSINE KINASE

Process for the preparation of vortioxetine salts

Crystalline forms of a hepatitis B antiviral agent

Crystal forms of azetidinone compounds and preparing methods thereof

Crystal forms of azetidinone compounds and preparing methods thereof

Solabegron zwitterion and uses thereof

Synthetic process

Crystalline diacylhydrazine and the use thereof

Method for using nanoparticles as nucleation agents for the crystallization of proteins

Cocrystals of progesterone

Use of polyols to obtain stable polymorphous forms of rifaximin

Method and apparatus for preparation of lactide using lactide purification process

Compositions for modulating a kinase cascade and methods of use thereof

Crystalline forms of fosnetupitant

Polymorphs of cabozantinib (S)-malate and cabozantinib free base

Solvated crystal form of rifaximin, production, compositions and uses thereof

Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

Process for pomalidomide

(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acid

DTPA prodrugs, compositions thereof, and methods of using the same

Polymorphs and new solid states of tiacumicin B

Crystals of dispiropyrrolidine derivatives

Crystals of dispiropyrrolidine derivatives

Crystals of dispiropyrrolidine derivatives

Crystals of dispiropyrrolidine derivatives

Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein

2-[[[2-[(Hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-N-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzenesulfonate, crystal of same, crystal polymorph thereof, and methods for production thereof

Crystalline freebase forms of a biphenyl compound

Crystal forms of sialic acid or salt or solvate thereof

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

Crystal form of dabigatran etexilate mesylate and preparation method and use thereof

Crystal form III of (S)-oxiracetam, preparation method and use thereof

SOLID PRODRUG FORMS OF 2'-CHLORO-2'-METHYL URIDINE FOR HCV

SOLID FORMS OF A FLAVIVIRIDAE VIRUS INHIBITOR COMPOUND AND SALTS THEREOF

Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same

CRYSTALLINE BROMODOMAIN INHIBITORS

Purification of taxanes

PROCESS FOR THE PREPARATION OF STABLE CRYSTALLINE FORM-I OF LINEZOLID, SUBSTANTIALLY FREE OF RESIDUAL SOLVENT

Energetic high pressure polymorph of croconic acid and high energy compositions formed therefrom

Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size

Process for preparing novel forms of tiacumicin B

Stable crystal form of tipiracil hydrochloride and crystallization method for the same

Polymorphic form of [5-fluoro-3-({2-[(4-fluorobenzene) sulfonyl]pyridin-3-yl}methyl)-2-methylindol-1-yl]-acetic acid

Process for the preparation of histamine H3 receptor modulators

Forms of apremilast and the process of making the same

Crystal of pyrrole derivative and method for producing the same

Rebaudioside A Crystal And Its Preparation Method And Use

NEW CRYSTALLINE FORM OF CEFAMANDOLE SODIUM COMPOUND, FORMULATION AND PREPARATION METHOD THEREOF

Crystal of doripenem, and preparation method therefor

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

Crystalline form of chlorogenic acid and preparation method thereof

Crystal form of Cefathiamidine compound and preparation method therefor

Crystalline form of tiotropium bromide with lactose

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-YL)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one as tor kinase inhibitors

CGRP receptor antagonists

Pharmaceutical salts of an orexin receptor antagonist

CGRP receptor antagonists

Omeprazole Sodium semihydrate and preparation method thereof

S-crystal form of ivabradine hydrochloride, and preparation method and pharmaceutical composition thereof

Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

Process for the preparation of rifamycin derivatives

Method for preparing spherical Clopidogrel Hydrogen Sulfate polymorph I

CRYSTALLINE FORMS OF 4-[2-(4-METHYLPHENYLSULFANYL)-PHENYL] PIPERIDINE

Solid forms of a pharmaceutically active compound

Polymorphic forms and co-crystals of a c-Met inhibitor

Crystal forms of ()-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-]pyrazin-1-yl)--(pyridin-2-yl)benzamide

Enzalutamide polymorphic forms and its preparation

Crystallization method and bioavailability

CRYSTALLIZATION METHOD AND BIOAVAILABILITY

NOVEL CRYSTALLINE FORMS

HIGH-PURITY CRYSTALS OF ACTIVE BLOOD COAGULATION FACTOR X (FXA) INHIBITOR

Polymorphs

POLYMORPHIC FORMS OF 4,5-DIHYDRO-1H-PYRROLO[2,3-F]QUINOLINE-2,7,9-TRICARBOXYLIC ACID AND ITS DISODIUM SALT, PROCESS FOR THEIR PREPARATION AND THEIR USE

STABLE CRYSTALLINE NORIBOGAINE SALT ANSOLVATES

NORIBOGAINE SALT TABLETS

Intermediate compound for preparing rosuvastatin calcium and method for preparing rosuvastatin calcium therefrom

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

Polymorphic forms of the sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide

Process for preparing pridopidine

Amorphous form of a thiocolchicine derivative

SOLID STATE FORMS OF SOFOSBUVIR

NOVEL COMPOUNDS

Methods for the preparation of indacaterol and pharmaceutically acceptable salts thereof

Method for crystallization of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride

Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Process for preparing clomazone, novel form and use of the same

Method for producing indoline compound

CRYSTAL FORMS OF ASTAXANTHIN

Lithium styrene sulfonate

Crystal form of regadenoson and preparation method thereof

NOVEL CRYSTALLINE FORMS OF AN ANTIVIRAL BENZIMIDAZOLE COMPOUND

Echothiophate iodide process

Diaryl macrocycles as modulators of protein kinases

Crystalline form I of ibrutinib

Cycloalkane derivatives

Crystalline forms of tyrosine kinase inhibitors and their salts

Crystalline forms of a histone deacetylase inhibitor

Co-crystals of tramadol and coxibis

Chemical compounds

Porphyrin containing covalent organic frameworks and process for the preparation thereof

Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one

NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol

Process for preparing a diamine/dicarboxylic acid salt

Co-crystals, salts and solid forms of tenofovir alafenamide

Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists

Crystalline compounds

LEVALBUTEROL SALT

Crystal form

Carbidopa And L-Dopa Prodrugs And Methods Of Use

Synthesis and isolation of crystalline alkali metal arene radical anions

Crystalline forms of a PI3K inhibitor

SALTS OF (S)-7-(1-(9H-PURIN-6-YLAMINO)ETHYL)-6-(3-FLUOROPHENYL)-3-METHYL-5H-THIAZOLO[3,2-A]PYRIMIDIN-5-ONE

POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS

Polymorphic forms of naltrexone

Method for producing 1,4-benzoxazine compound

Polymorphs of 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloro-methylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide

Process for preparation of Darunavir

Compositions and uses thereof

Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

Preparation of hydroxy-benzylbenzene derivatives

Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof

NUCLEOSIDE PHOSPHORAMIDATES

Substituted naphthyridines as JAK kinase inhibitors

Crystalline forms of dolutegravir sodium

Preparation of sufentanil citrate and sufentanil base

Dapagliflozin crystalline form and preparation method thereof

Salts and co-crystals of lesinurad

(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide

Stable solid forms of enclomiphene and enclomiphene citrate

Methods for making active crystalline materials

Vitamin D Compounds and Methods for Preparing Same

(3A,9B,10A,13A,14B,17A,20S,22E)-ergosta-5,7,22-trien-3-ol and methods of preparing and using the same

Process for preparation of (2S,5R)-6-sulphooxy-7-oxo-2-[((3R)-piperidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1] octane

Separation method for active pharmaceutical ingredients (apis) from excipients in pharmaceutical formulations

Benzoimidazol-2-yl pyrimidine modulators of the histamine Hreceptor

Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Co-crystals and pharmaceutical compositions comprising the same

Process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof

Crystalline forms

(S)-CSA SALT OF S-KETAMINE, (R)-CSA SALT OF S-KETAMINE AND PROCESSES FOR THE PREPARATION OF S-KETAMINE

Crystalline forms of a prolyl hydroxylase inhibitor

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Process for the preparation of a PDE4 inhibitor

PROCESS FOR PREPARATION OF DIMETHYL-(E)-BUTENEDIOATE

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Solid forms of a thiophosphoramidate nucleotide prodrug

Process for the preparation of sofosbuvir

CRYSTAL (1) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUND

Tritoqualine hydrochloride in crystalline form and a process for obtaining same

Processes for the preparation of axitinib

De novo structural protein design for manufacturing high strength materials

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

BROMODOMAIN INHIBITOR

Perovskite material layer processing